HORSHAM, Pa., July 28 /PRNewswire/ -- Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR).

PRINCETON, N.J., June 3 /PRNewswire-FirstCall/ -- Soligenix, Inc.

PRINCETON, N.J., May 10 /PRNewswire-FirstCall/ -- Soligenix, Inc.

VIENNA, Sept. 16 /PRNewswire/ -- Teva Respiratory, a division of Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA), today announced results from an analysis of the cost-effectiveness of three different inhaled corticosteroids (ICSs) in a "real-life" asthmatic population.

The chief executive of the UK's Medicines and Healthcare products Regulatory Agency has written to healthcare professionals to ensure they are correctly prescribing CFC-free inhalers to treat asthma.